Macrogenics (MGNX) Amortizatization of Intangibles (2019 - 2026)
Macrogenics' (MGNX) quarterly Amortizatization of Intangibles came in at $737000.0 in Q1 2026, up 304.95% year-on-year from $182000.0 in Q1 2025, and up 14.44% on a QoQ basis from $644000.0 in Q4 2025.
Macrogenics (MGNX) Amortizatization of Intangibles (2019 - 2026) Analysis & Trends
Macrogenics (MGNX) has 8 years of Amortizatization of Intangibles data on file, last reported at $737000.0 in Q1 2026.
- On a quarterly basis, Amortizatization of Intangibles rose 304.95% year-over-year to $737000.0 in Q1 2026; TTM through Mar 2026 was $2.2 million, a 31.37% increase from a year earlier, with the FY2025 full-year figure at $1.6 million, down 41.35% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $737000.0, up from $644000.0 in the prior quarter.
- Over the last five years, Amortizatization of Intangibles for MGNX reached as high as $1.9 million in Q3 2023 and fell as low as -$334000.0 in Q1 2022.
- Historically, Amortizatization of Intangibles has averaged $576235.3 across 5 years, with a median of $372000.0 in 2023.
- Across the five-year window, Amortizatization of Intangibles surged 1771.43% in 2023 and sank 89.29% in 2024, its largest moves.
- Year by year, Amortizatization of Intangibles stood at $337000.0 in 2022, then surged by 412.76% to $1.7 million in 2023, then plunged by 89.29% to $185000.0 in 2024, then soared by 248.11% to $644000.0 in 2025, then increased by 14.44% to $737000.0 in 2026.
- Per Business Quant data, the three most recent Amortizatization of Intangibles figures were $737000.0 in Q1 2026, $644000.0 in Q4 2025, and $511000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Macrogenics | 255.39 Mn | 188.87 Mn | - | 737,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 737,000.00 |
| Mar 31, 2026 | 737,000.00 |
| Dec 31, 2025 | 644,000.00 |
| Dec 31, 2025 | 644,000.00 |
| Sep 30, 2025 | 511,000.00 |
| Sep 30, 2025 | 511,000.00 |
| Jun 30, 2025 | 311,000.00 |
| Jun 30, 2025 | 311,000.00 |
| Mar 31, 2025 | 182,000.00 |
| Mar 31, 2025 | 182,000.00 |
| Dec 31, 2024 | 185,000.00 |
| Dec 31, 2024 | 185,000.00 |
| Sep 30, 2024 | 371,000.00 |
| Sep 30, 2024 | 371,000.00 |
| Jun 30, 2024 | 939,000.00 |
| Jun 30, 2024 | 939,000.00 |
| Mar 31, 2024 | 1.32 Mn |
| Mar 31, 2024 | 1.32 Mn |
| Dec 31, 2023 | 1.73 Mn |
| Dec 31, 2023 | 1.73 Mn |